Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-09-22 Mills Kenneth T. Director Conversion · Series C Preferred Stock −15,440 0
2015-09-16 BESHAR LUKE M Director Grant or award · Stock Option (Right to Buy) +9,375 9,375
2015-09-16 HAYDEN DONALD J JR Director Grant or award · Stock Option (Right to Buy) +9,375 9,375
2015-09-16 KARABELAS ARGERIS N Director Grant or award · Stock Option (Right to Buy) +9,375 9,375

Page 56 of 56 · 1,104 trades